140 related articles for article (PubMed ID: 36633207)
1. Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean males.
Heo JE; Kim DG; Yoo JW; Lee KS
Aging Male; 2023 Dec; 26(1):6-12. PubMed ID: 36633207
[TBL] [Abstract][Full Text] [Related]
2. Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia.
Lee D; Koo KC; Yoo JW; Lee KS
Low Urin Tract Symptoms; 2022 Jan; 14(1):35-40. PubMed ID: 34323012
[TBL] [Abstract][Full Text] [Related]
3. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
4. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea.
Yoo TK; Lee KS; Sumarsono B; Kim ST; Kim HJ; Lee HC; Kim SH
Investig Clin Urol; 2018 May; 59(3):166-176. PubMed ID: 29744473
[TBL] [Abstract][Full Text] [Related]
7. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links.
He Q; Wang Z; Liu G; Daneshgari F; MacLennan GT; Gupta S
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):7-13. PubMed ID: 26391088
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men.
Park YW; Min SK; Lee JH
World J Mens Health; 2012 Dec; 30(3):183-8. PubMed ID: 23596610
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
[TBL] [Abstract][Full Text] [Related]
11. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
[TBL] [Abstract][Full Text] [Related]
12. Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study.
Pozzi E; Boeri L; Capogrosso P; Cazzaniga W; Candela L; Fallara G; Schifano N; Costa A; Cignoli D; Tutolo M; Matloob R; Abbate C; Montorsi F; Salonia A
Eur Urol Focus; 2022 Mar; 8(2):555-562. PubMed ID: 33757736
[TBL] [Abstract][Full Text] [Related]
13. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.
Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Chisari M; Castelli T; Favilla V; Morgia G
World J Urol; 2015 May; 33(5):743-51. PubMed ID: 25189458
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
Zhao S; Tang J; Shao S; Yan Y
Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
[TBL] [Abstract][Full Text] [Related]
16. The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.
Doğan Y; Uruç F; Aras B; Şahin A; Kıvrak M; Ürkmez A; Güner ND; Aydın S
Turk J Urol; 2015 Mar; 41(1):7-12. PubMed ID: 26328190
[TBL] [Abstract][Full Text] [Related]
17. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
[TBL] [Abstract][Full Text] [Related]
18. Impact of serum 25-OH vitamin D level on lower urinary tract symptoms in men: a step towards reducing overactive bladder.
Yoo S; Oh S; Kim HS; Choi HS; Park J; Cho SY; Son H; Jeong H; Lee HW; Cho MC
BJU Int; 2018 Oct; 122(4):667-672. PubMed ID: 29745000
[TBL] [Abstract][Full Text] [Related]
19. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
[TBL] [Abstract][Full Text] [Related]
20. Benign prostatic hyperplasia and metabolic syndrome; prevalence and association: a cross-sectional study in Syria.
Daher M; Saqer T; Jabr M; Al-Mousa S
BMC Urol; 2023 Nov; 23(1):187. PubMed ID: 37974176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
